Eric Schmidt FCA
Stock Analyst at Cantor Fitzgerald
(4.85)
# 396
Out of 5,022 analysts
45
Total ratings
45.5%
Success rate
77%
Average return
Main Sectors:
Stocks Rated by Eric Schmidt FCA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRIM Primoris Services | Reiterated: Hold | $105 | $76.25 | +37.70% | 1 | Sep 29, 2026 | |
| FDMT 4D Molecular Therapeutics | Upgraded: Buy | n/a | $13.84 | - | 1 | Sep 21, 2026 | |
| DYN Dyne Therapeutics | Initiated Coverage: Buy | n/a | $15.82 | - | 1 | Jul 23, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | $206 | $222.82 | -7.55% | 4 | Jun 22, 2026 | |
| ODTX Odyssey Therapeutics | Initiated Coverage: Buy | n/a | $20.42 | - | 1 | Jun 2, 2026 | |
| LONA LeonaBio | Reiterated: Buy | n/a | $4.38 | - | 2 | Apr 7, 2026 | |
| GENB Generate Biomedicines | Initiated Coverage: Buy | n/a | $13.80 | - | 1 | Mar 24, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | n/a | $46.16 | - | 2 | Mar 19, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $75 → $74 | $19.32 | +283.02% | 4 | Dec 17, 2025 | |
| VSTM Verastem | Initiated Coverage: Buy | n/a | $7.90 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.21 | n/a | 3 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $66.91 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.94 | n/a | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.69 | n/a | 8 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.65 | n/a | 1 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.54 | n/a | 2 | Jun 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.44 | n/a | 3 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $32.48 | n/a | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.26 | n/a | 1 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.08 | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $117.14 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $24.45 | n/a | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $30.54 | n/a | 1 | Nov 2, 2023 |
Primoris Services
Sep 29, 2026
Reiterated: Hold
Price Target: $105
Current: $76.25
Upside: +37.70%
4D Molecular Therapeutics
Sep 21, 2026
Upgraded: Buy
Price Target: n/a
Current: $13.84
Upside: -
Dyne Therapeutics
Jul 23, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $15.82
Upside: -
Biogen
Jun 22, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $222.82
Upside: -7.55%
Odyssey Therapeutics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $20.42
Upside: -
LeonaBio
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.38
Upside: -
Generate Biomedicines
Mar 24, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $13.80
Upside: -
Scholar Rock Holding
Mar 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $46.16
Upside: -
Legend Biotech
Dec 17, 2025
Reiterated: Buy
Price Target: $75 → $74
Current: $19.32
Upside: +283.02%
Verastem
Oct 16, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $7.90
Upside: -
Aug 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.21
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $66.91
Upside: n/a
Aug 13, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $3.94
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.69
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $33.65
Upside: n/a
Jun 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.54
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.44
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $32.48
Upside: n/a
Mar 21, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $14.26
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.08
Upside: n/a
Apr 23, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $117.14
Upside: n/a
Apr 4, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $24.45
Upside: n/a
Nov 2, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $30.54
Upside: n/a